Researcher - Peptide

勤務地 東京都
業界・業種 医療・製薬
契約タイプ Permanent
給料
参照番号 35458

 【COMPANY OVERVIEW】

Global Biotechnology Company specializing in the expression and purification of disulfide-rich peptides and membrane proteins using their own special product which helps in drug discovery. 

 

【JOB RESPONSIBILITIES】

  • This position is responsible for the expression and purification of disulfide-rich peptides (DRPs) in E. coli and the analysis of DRPs by chromatography and electrophoresis.

  • Involved in the discovery of functional DRPs using our proprietary screening platform technology, the PERISS method.

  • Developing a business to identify peptides that act on drug discovery target molecules/agrochemical target molecules of pharmaceutical companies/agrochemical manufacturers by utilizing our proprietary peptide screening technology, PERISS method, for difficult-to-target membrane proteins such as ion channels and G protein-coupled receptors (GPCRs), and to license them as drug candidates for pharmaceutical companies/agrochemical manufacturers.

  • Developing a business to identify peptides that act on drug discovery of target molecules/agrochemical target molecules for pharmaceutical companies/agrochemical

  • manufacturers and license them to pharmaceutical companies/agrochemical manufacturers as drug candidates”

【WHY YOU SHOULD APPLY】

  • Huge scope for career growth

  • Flexible and Global environment

【REQUIREMENTS】

  • Master’s degree or above in biology, cell biology, Molecular Biology, Immunology, Biotechnology or other life science-related fields.

  • Mastery of various genetic engineering techniques and biochemical experimental techniques

  • Experience in the expression and purification of peptides and proteins using E. coli. Experience with the use of a jar fermenter is a plus.

  • Familiarity with chromatographic (AKTA) and electrophoretic analysis of peptides and proteins, preferably using LC-MS. 4.

  • Experience with expression by E. coli of membrane proteins such as ion channels and GCPRs, which are drug targets."